Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

6 Biotech Stocks That Analysts Give The Green Light
Seeking Alpha
Friday, July 27, 2012 - 12:05pm
tags:
GTx, Illumina, InterMune, QLT, Seattle Genetics, Vivus
Gilead Begins Single Pill Hepatitis C Study For 2014 Approval
Bloomberg
Friday, July 27, 2012 - 12:02pm
tags:
GS-7977, hepatitis C, Gilead
3 Healthcare Mid Caps With Strong EPS Growth Projections And Analyst Backing
Seeking Alpha
Friday, July 27, 2012 - 11:55am
tags:
Vivus, Biomarin, Alkermes
Amgen, Gilead Pop After Quarterly Earnings Beats
Investors.com
Friday, July 27, 2012 - 11:41am
tags:
earnings, Amgen, Gilead
Sequenom shares fall after 2Q misses expectations
Yahoo/AP
Friday, July 27, 2012 - 11:39am
tags:
Sequenom, earnings
Bristol-Myers Gets Record Low Coupons In $2 Billion Debt Issue
Bloomberg
Friday, July 27, 2012 - 11:38am
tags:
Bristol-Myers Squibb, debt
India considers price controls for patented drugs
Reuters
Friday, July 27, 2012 - 11:36am
tags:
India
Alzheimer’s Setback Makes Elan Takeover Bait To Biogen
Bloomberg
Friday, July 27, 2012 - 8:17am
tags:
Elan, Biogen Idec, Alzheimer's disease, M&A, bapineuzumab
Besides That Bristol, How Was the Show?
Motley Fool
Friday, July 27, 2012 - 8:14am
tags:
Bristol-Myers Squibb, earnings
Merck Profit Tops Estimates As Sales Of Diabetes Drugs Grow
Bloomberg
Friday, July 27, 2012 - 8:10am
tags:
earnings, Merck
Horizon Wins Approval For Rayos Rheumatoid Arthritis Drug
Bloomberg
Thursday, July 26, 2012 - 10:54pm
tags:
Rayos, rheumatoid arthritis, Horizon Pharma, FDA
Amarin Wins Approval For Debut Drug To Treat High Blood Fats
Bloomberg
Thursday, July 26, 2012 - 10:50pm
tags:
Amarin, FDA, fish oil, AMR101, Vascepa
Sanofi posts slower Q2 drop, keeps 2012 outlook
Reuters
Thursday, July 26, 2012 - 11:07am
tags:
earnings, Sanofi
Eli Lilly and Company Earnings Call INSIGHTS: Insulin Numbers, Prudent Expense Management
Wall St. Cheat Sheet
Thursday, July 26, 2012 - 11:02am
tags:
earnings, Eli Lilly
Pfizer Needs Big Earnings Beat
TheStreet.com
Thursday, July 26, 2012 - 10:37am
tags:
earnings, Pfizer
Sanofi CEO Pledges ‘Thoughtful’ Job Cuts To Avoid Peugeot Drama
Bloomberg
Thursday, July 26, 2012 - 10:34am
tags:
Chris Viehbacher, Sanofi, layoffs, reorganization
Roche First-Half Profit Drops on Costs to Shut N.J. Site
Bloomberg
Thursday, July 26, 2012 - 10:13am
tags:
earnings, Roche
In Conversations About Potential To Treat Alzheimer's, Don't Forget Baxter's Gammagard
Forbes
Thursday, July 26, 2012 - 10:11am
tags:
Baxter, Alzheimer's disease, Gammagard
AMRN FDA Approval Likely Today
Forbes
Thursday, July 26, 2012 - 10:09am
tags:
FDA, Amarin, AMR101, fish oil
Pluristem, NIH to study stem cells to treat radiation syndrome
Reuters
Thursday, July 26, 2012 - 9:30am
tags:
Pluristem, NIH, stem cells, radiation syndrome

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.